World Parkinson’s Day: advancing treatment options with cell therapies, gene therapies and novel biologics
Over 11 million people worldwide are estimated to live with Parkinson’s disease, the fastest growing neurological condition in the world. Taking place annually on 11 April, World Parkinson’s Day aims to promote research and support for those living with the condition.
Current treatments for Parkinson’s, including levodopa and dopamine agonists, can effectively reduce symptoms, especially in the early stages. However, they do not slow or stop disease progression and their effectiveness typically diminishes over time.
Rather than just managing symptoms, regenerative approaches aim to repair or replace the neurons that are lost or damaged in Parkinson’s disease. While these approaches are still largely in development, they offer the potential to modify the course of Parkinson’s disease and maybe one day, reverse it. In this article, RegMedNet explores some regenerative and advanced therapies for Parkinson’s disease that have caught their eye.
